Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
Contact Us
Versions and log file
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
SELPERCATINIB
(2020)
Small molecule
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor
Unknown
Approved
Carcinoma, Medullary; Carcinoma, Non-Small-Cell Lung; Neoplasms; Thyroid Neoplasms
SELPERCATINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
CEGM9YBNGD
Molecule Type:
Small molecule
Molecular Formula:
C29H31N7O3
Molecular Weight:
525.61
AlogP:
3.28
PSA:
112.04
HBD:
1.0
HBA:
#RotB:
8.0
Source:
CALCIUM OXYBATE
(2020)
Small molecule
GABA-B receptor agonist
Unknown
Approved
Unknown
CALCIUM OXYBATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
8W24SYD6ZI
Molecule Type:
Small molecule
Molecular Formula:
C8H14CaO6
Molecular Weight:
246.27
AlogP:
-0.16
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
OPICAPONE
(2020)
Small molecule
Catechol O-methyltransferase inhibitor
Unknown
Approved
Parkinson Disease
OPICAPONE
×
Maximum Phase:
4
First Approval:
2020
UNII:
Y5929UIJ5N
Molecule Type:
Small molecule
Molecular Formula:
C15H10Cl2N4O6
Molecular Weight:
413.17
AlogP:
3.28
PSA:
149.46
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BEROTRALSTAT
(2020)
Small molecule
Unknown
Unknown
Approved
Angioedemas, Hereditary
BEROTRALSTAT
×
Maximum Phase:
4
First Approval:
2020
UNII:
XZA0KB1BDQ
Molecule Type:
Small molecule
Molecular Formula:
C30H26F4N6O
Molecular Weight:
562.57
AlogP:
5.7
PSA:
108.76
HBD:
3.0
HBA:
#RotB:
9.0
Source:
RISDIPLAM
(2020)
Small molecule
SMN2 pre-mRNA positive modulator
Unknown
Approved
Atrophy; Muscular Atrophy, Spinal
RISDIPLAM
×
Maximum Phase:
4
First Approval:
2020
UNII:
76RS4S2ET1
Molecule Type:
Small molecule
Molecular Formula:
C22H23N7O
Molecular Weight:
401.47
AlogP:
1.96
PSA:
79.83
HBD:
1.0
HBA:
#RotB:
2.0
Source:
NIFURTIMOX
(2020)
Small molecule
DNA inhibitor
Unknown
Approved
Chagas Disease; Leishmaniasis; Trypanosomiasis
NIFURTIMOX
×
Maximum Phase:
4
First Approval:
2020
UNII:
M84I3K7C2O
Molecule Type:
Small molecule
Molecular Formula:
C10H13N3O5S
Molecular Weight:
287.3
AlogP:
0.64
PSA:
106.02
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PRALSETINIB
(2020)
Small molecule
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET inhibitor
Unknown
Approved
Carcinoma, Medullary; Carcinoma, Non-Small-Cell Lung; Neoplasms
PRALSETINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
1WPE73O1WV
Molecule Type:
Small molecule
Molecular Formula:
C27H32FN9O2
Molecular Weight:
533.61
AlogP:
4.2
PSA:
135.53
HBD:
3.0
HBA:
#RotB:
8.0
Source:
AMISULPRIDE
(2020)
Small molecule
Dopamine receptors; D2 & D3 antagonist
Unknown
Approved
Postoperative Nausea and Vomiting; Psychotic Disorders
AMISULPRIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
8110R61I4U
Molecule Type:
Small molecule
Molecular Formula:
C17H27N3O4S
Molecular Weight:
369.49
AlogP:
1.29
PSA:
101.73
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TAZEMETOSTAT
(2020)
Small molecule
Unknown
Unknown
Approved
Neoplasms
TAZEMETOSTAT
×
Maximum Phase:
4
First Approval:
2020
UNII:
Q40W93WPE1
Molecule Type:
Small molecule
Molecular Formula:
C34H44N4O4
Molecular Weight:
572.75
AlogP:
4.73
PSA:
86.9
HBD:
2.0
HBA:
#RotB:
9.0
Source:
VIBEGRON
(2020)
Small molecule
Beta-3 adrenergic receptor agonist
Unknown
Approved
Urinary Bladder, Overactive; Urinary Incontinence; Urinary Incontinence, Urge
VIBEGRON
×
Maximum Phase:
4
First Approval:
2020
UNII:
M5TSE03W5U
Molecule Type:
Small molecule
Molecular Formula:
C26H28N4O3
Molecular Weight:
444.54
AlogP:
2.77
PSA:
96.25
HBD:
3.0
HBA:
#RotB:
6.0
Source:
FLUOROESTRADIOL
(2020)
Small molecule
Unknown
Unknown
Approved
Unknown
FLUOROESTRADIOL
×
Maximum Phase:
4
First Approval:
2020
UNII:
LVI5P34A3C
Molecule Type:
Small molecule
Molecular Formula:
C18H23FO2
Molecular Weight:
290.38
AlogP:
3.56
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
FOSTEMSAVIR TROMETHAMINE
(2020)
Small molecule
Envelope polyprotein GP160 inhibitor
Unknown
Approved
Autoimmune Diseases; HIV Infections
FOSTEMSAVIR TROMETHAMINE
×
Maximum Phase:
4
First Approval:
2020
UNII:
2X513P36U0
Molecule Type:
Small molecule
Molecular Formula:
C29H37N8O11P
Molecular Weight:
704.63
AlogP:
1.17
PSA:
182.21
HBD:
2.0
HBA:
#RotB:
8.0
Source:
TUCATINIB
(2020)
Small molecule
Receptor protein-tyrosine kinase erbB-2 inhibitor
Unknown
Approved
Brain Neoplasms; Breast Neoplasms; Neoplasms
TUCATINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
234248D0HH
Molecule Type:
Small molecule
Molecular Formula:
C26H24N8O2
Molecular Weight:
480.53
AlogP:
5.09
PSA:
110.85
HBD:
2.0
HBA:
#RotB:
5.0
Source:
FOSTEMSAVIR
(2020)
Small molecule
Envelope polyprotein GP160 inhibitor
Unknown
Approved
HIV Infections; Virus Diseases
FOSTEMSAVIR
×
Maximum Phase:
4
First Approval:
2020
UNII:
97IQ273H4L
Molecule Type:
Small molecule
Molecular Formula:
C25H26N7O8P
Molecular Weight:
583.5
AlogP:
1.17
PSA:
182.21
HBD:
2.0
HBA:
#RotB:
8.0
Source:
OLICERIDINE
(2020)
Small molecule
Mu opioid receptor agonist
Unknown
Approved
Acute Pain; Pain
OLICERIDINE
×
Maximum Phase:
4
First Approval:
2020
UNII:
MCN858TCP0
Molecule Type:
Small molecule
Molecular Formula:
C22H30N2O2S
Molecular Weight:
386.56
AlogP:
4.69
PSA:
43.38
HBD:
1.0
HBA:
#RotB:
7.0
Source:
CLASCOTERONE
(2020)
Small molecule
Androgen Receptor antagonist
Unknown
Approved
Acne Vulgaris
CLASCOTERONE
×
Maximum Phase:
4
First Approval:
2020
UNII:
XN7MM8XG2M
Molecule Type:
Small molecule
Molecular Formula:
C24H34O5
Molecular Weight:
402.53
AlogP:
3.77
PSA:
80.67
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CENOBAMATE
(2020)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
Unknown
Approved
Epilepsy; Seizures
CENOBAMATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
P85X70RZWS
Molecule Type:
Small molecule
Molecular Formula:
C10H10ClN5O2
Molecular Weight:
267.68
AlogP:
1.16
PSA:
95.92
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RELUGOLIX
(2020)
Small molecule
Gonadotropin-releasing hormone receptor antagonist
Unknown
Approved
Neoplasms; Prostatic Neoplasms
RELUGOLIX
×
Maximum Phase:
4
First Approval:
2020
UNII:
P76B05O5V6
Molecule Type:
Small molecule
Molecular Formula:
C29H27F2N7O5S
Molecular Weight:
623.64
AlogP:
3.75
PSA:
132.61
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LACTITOL
(2020)
Small molecule
Osmotic agent
Unknown
Approved
Constipation
LACTITOL
×
Maximum Phase:
4
First Approval:
2020
UNII:
L2B0WJF7ZY
Molecule Type:
Small molecule
Molecular Formula:
C12H24O11
Molecular Weight:
344.31
AlogP:
-5.76
PSA:
200.53
HBD:
9.0
HBA:
#RotB:
8.0
Source:
TAZEMETOSTAT HYDROBROMIDE
(2020)
Small molecule
Histone-lysine N-methyltransferase EZH2 inhibitor
Unknown
Approved
Lymphoma, Follicular; Sarcoma
TAZEMETOSTAT HYDROBROMIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
6P89T5M073
Molecule Type:
Small molecule
Molecular Formula:
C34H45BrN4O4
Molecular Weight:
653.66
AlogP:
4.73
PSA:
86.9
HBD:
2.0
HBA:
#RotB:
9.0
Source:
LONAFARNIB
(2020)
Small molecule
Protein farnesyltransferase inhibitor
Unknown
Approved
Progeria
LONAFARNIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
IOW153004F
Molecule Type:
Small molecule
Molecular Formula:
C27H31Br2ClN4O2
Molecular Weight:
638.83
AlogP:
5.91
PSA:
79.53
HBD:
1.0
HBA:
#RotB:
3.0
Source:
REMIMAZOLAM BESYLATE
(2020)
Small molecule
GABA-A receptor; anion channel positive allosteric modulator
Unknown
Approved
Unknown
REMIMAZOLAM BESYLATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
280XQ6482H
Molecule Type:
Small molecule
Molecular Formula:
C27H25BrN4O5S
Molecular Weight:
597.49
AlogP:
4.18
PSA:
69.37
HBD:
0.0
HBA:
#RotB:
4.0
Source:
FENFLURAMINE
(2020)
Small molecule
Unknown
Unknown
Approved
Epilepsy; Obesity
FENFLURAMINE
×
Maximum Phase:
4
First Approval:
2020
UNII:
2DS058H2CF
Molecule Type:
Small molecule
Molecular Formula:
C12H16F3N
Molecular Weight:
231.26
AlogP:
3.25
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RIMEGEPANT SULFATE
(2020)
Small molecule
Calcitonin gene-related peptide type 1 receptor antagonist
Unknown
Approved
Migraine Disorders
RIMEGEPANT SULFATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
1383NM3Q0H
Molecule Type:
Small molecule
Molecular Formula:
C56H64F4N12O13S
Molecular Weight:
1221.26
AlogP:
4.49
PSA:
119.13
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TIRBANIBULIN
(2020)
Small molecule
Tyrosine-protein kinase SRC inhibitor
Unknown
Approved
Keratosis, Actinic
TIRBANIBULIN
×
Maximum Phase:
4
First Approval:
2020
UNII:
4V9848RS5G
Molecule Type:
Small molecule
Molecular Formula:
C26H29N3O3
Molecular Weight:
431.54
AlogP:
3.32
PSA:
63.69
HBD:
1.0
HBA:
#RotB:
9.0
Source:
LASMIDITAN SUCCINATE
(2020)
Small molecule
Serotonin 1f (5-HT1f) receptor agonist
Unknown
Approved
Migraine Disorders
LASMIDITAN SUCCINATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
W64YBJ346B
Molecule Type:
Small molecule
Molecular Formula:
C42H42F6N6O8
Molecular Weight:
872.82
AlogP:
3.28
PSA:
62.3
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CAPMATINIB HYDROCHLORIDE
(2020)
Small molecule
Hepatocyte growth factor receptor inhibitor
Unknown
Approved
Carcinoma, Non-Small-Cell Lung
CAPMATINIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2020
UNII:
C2A374O70X
Molecule Type:
Small molecule
Molecular Formula:
C23H21Cl2FN6O2
Molecular Weight:
503.37
AlogP:
3.43
PSA:
85.07
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LEMBOREXANT
(2020)
Small molecule
Orexin receptor 1 antagonist
Unknown
Approved
Sleep Initiation and Maintenance Disorders
LEMBOREXANT
×
Maximum Phase:
4
First Approval:
2020
UNII:
0K5743G68X
Molecule Type:
Small molecule
Molecular Formula:
C22H20F2N4O2
Molecular Weight:
410.42
AlogP:
3.74
PSA:
77.0
HBD:
1.0
HBA:
#RotB:
6.0
Source:
SELUMETINIB
(2020)
Small molecule
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
Unknown
Approved
Neoplasms
SELUMETINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
6UH91I579U
Molecule Type:
Small molecule
Molecular Formula:
C17H15BrClFN4O3
Molecular Weight:
457.69
AlogP:
3.53
PSA:
88.41
HBD:
3.0
HBA:
#RotB:
6.0
Source:
FLUOROESTRADIOL F-18
(2020)
Small molecule
Diagnostic agent
Unknown
Approved
Breast Neoplasms
FLUOROESTRADIOL F-18
×
Maximum Phase:
4
First Approval:
2020
UNII:
T32277KB09
Molecule Type:
Small molecule
Molecular Formula:
C18H23FO2
Molecular Weight:
289.38
AlogP:
3.56
PSA:
40.46
HBD:
2.0
HBA:
#RotB:
0.0
Source:
POTASSIUM OXYBATE
(2020)
Small molecule
GABA-B receptor agonist
Unknown
Approved
Unknown
POTASSIUM OXYBATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
S8NKF3H3KT
Molecule Type:
Small molecule
Molecular Formula:
C4H7KO3
Molecular Weight:
142.19
AlogP:
-0.16
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
BEMPEDOIC ACID
(2020)
Small molecule
ATP-citrate synthase inhibitor
Unknown
Approved
Atherosclerosis; Cardiovascular Diseases; Coronary Artery Disease; Hyperlipoproteinemia Type II
BEMPEDOIC ACID
×
Maximum Phase:
4
First Approval:
2020
UNII:
1EJ6Z6Q368
Molecule Type:
Small molecule
Molecular Formula:
C19H36O5
Molecular Weight:
344.49
AlogP:
4.47
PSA:
94.83
HBD:
3.0
HBA:
#RotB:
14.0
Source:
RIMEGEPANT
(2020)
Small molecule
Calcitonin gene-related peptide type 1 receptor antagonist
Unknown
Approved
Migraine Disorders
RIMEGEPANT
×
Maximum Phase:
4
First Approval:
2020
UNII:
997WVV895X
Molecule Type:
Small molecule
Molecular Formula:
C28H28F2N6O3
Molecular Weight:
534.57
AlogP:
4.49
PSA:
119.13
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TRIHEPTANOIN
(2020)
Small molecule
Supplement
Unknown
Approved
Unknown
TRIHEPTANOIN
×
Maximum Phase:
4
First Approval:
2020
UNII:
2P6O7CFW5K
Molecule Type:
Small molecule
Molecular Formula:
C24H44O6
Molecular Weight:
428.61
AlogP:
5.9
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
20.0
Source:
ARTESUNATE
(2020)
Small molecule
Unknown
Unknown
Approved
Malaria
ARTESUNATE
×
Maximum Phase:
4
First Approval:
2020
UNII:
60W3249T9M
Molecule Type:
Small molecule
Molecular Formula:
C19H28O8
Molecular Weight:
384.43
AlogP:
2.6
PSA:
100.52
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RIPRETINIB
(2020)
Small molecule
Platelet-derived growth factor receptor alpha inhibitor
Unknown
Approved
Gastrointestinal Stromal Tumors; Neoplasms
RIPRETINIB
×
Maximum Phase:
4
First Approval:
2020
UNII:
9XW757O13D
Molecule Type:
Small molecule
Molecular Formula:
C24H21BrFN5O2
Molecular Weight:
510.37
AlogP:
5.67
PSA:
88.05
HBD:
3.0
HBA:
#RotB:
5.0
Source:
1
2
…
71
72
73
74
75
76
77
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA